BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 22
• 23
• 24
• 25
• 28

• Genetic Find Holds Clue to Curing Skin Cancer, University of Dundee Study

  February 28, 2011

   · 

  1 min read
• Major Clinical Trial Investigates Intraoperative Defibrillator Testing While Using BIOTRONIK Home Monitoring(R) For Continuous Therapy Surveillance

  February 28, 2011

   · 

  1 min read
• Pharm Country

  Quick, Easy Test Identifies Aggressive Type of Lung Cancer in Never-Smokers, Mayo Clinic Study

  February 28, 2011

   · 

  1 min read
• Drug Development

  Regeneron Pharmaceuticals, Inc.'s ARCALYST(R) (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy

  February 28, 2011

   · 

  13 min read
• FDA

  FDA Approves Shire plc’s INTUNIV(R) (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents

  February 28, 2011

   · 

  9 min read
• Policy

  Shire plc Files Complete Response to Shire Pharmaceuticals’s Not Approvable Letter for FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema

  February 28, 2011

   · 

  5 min read
• Genetown

  CardioFocus Inc. Raises $30.6 Million in Private Financing

  February 28, 2011

   · 

  2 min read
• Drug Development

  Harbor BioSciences, Inc. Preclinical Study of Apoptone(R) in Breast Cancer Published in the International Journal of Breast Cancer

  February 28, 2011

   · 

  1 min read
• BioForest

  biOasis Release: Cognitest(TM) - Diagnostic Blood Test for Alzheimer’s Disease - Milestone Attained

  February 28, 2011

   · 

  1 min read
• Neptune Technologies & Bioressources Inc. Subsidiary Acasti Pharma Receives Conditional Approval for Listing on TSX-Venture

  February 28, 2011

   · 

  1 min read